Treatment of Optic Neuritis With Erythropoietin: a Randomised, Double-blind, Placebo-controlled Trial

PHASE3CompletedINTERVENTIONAL
Enrollment

108

Participants

Timeline

Start Date

November 25, 2014

Primary Completion Date

June 20, 2018

Study Completion Date

November 26, 2019

Conditions
Optic Neuritis
Interventions
DRUG

Erythropoietin alfa

DRUG

Placebo

Trial Locations (11)

20246

University Medical Center Hamburg-Eppendorf, Hamburg

30625

Hannover Medical School, Hanover

37075

University Medical Center Göttingen, Göttingen

40225

Duesseldorf University Hospital, Düsseldorf

55131

University Medical Center of the Johannes Gutenberg University Mainz, Mainz

69120

Heidelberg University Hospital, Department of Neurooncology, Heidelberg

72076

Tuebingen University Hospital, Tübingen

79106

Medical Center - University of Freiburg, Eye Hospital, Freiburg im Breisgau

81377

University Hospital of Munich, Munich

81675

University Hospital Klinikum rechts der Isar, Munich, Munich

91054

University Hospital Erlangen, Erlangen

All Listed Sponsors
collaborator

German Federal Ministry of Education and Research

OTHER_GOV

lead

University Eye Hospital, Freiburg

OTHER

NCT01962571 - Treatment of Optic Neuritis With Erythropoietin: a Randomised, Double-blind, Placebo-controlled Trial | Biotech Hunter | Biotech Hunter